Tauns Laboratories (TSE:197A) Revenue: 円14,369 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
14 GF Score
Price 円509.00
! 9 Warning Signs
View Full Analysis

What is Tauns Laboratories Revenue?

Tauns Laboratories TSE:197A +1.19% 14 Revenue is 円14,369 Mil as of Mar. 2026. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 9 warning signs investors should review.

Tauns Laboratories's revenue for the three months ended in Mar. 2026 was 円2,387 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円14,369 Mil. Tauns Laboratories's Revenue per Share for the three months ended in Mar. 2026 was 円22.20. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円133.68.

Warning Sign:

Tauns Laboratories Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Tauns Laboratories was -23.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Tauns Laboratories's highest 3-Year average Revenue per Share Growth Rate was -0.20% per year. The lowest was -5.20% per year. And the median was -2.70% per year.


Tauns Laboratories  (TSE:197A) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Tauns Laboratories Revenue Related Terms


Tauns Laboratories Revenue Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Revenue Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Revenue
17,456.99 15,673.10 18,434.86 18,627.99 14,369.22

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,020.07 2,368.41 5,908.17 2,386.91 3,705.73

TSE:197A vs ISRG, BDX, MDLN: Revenue Comparison

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Revenue distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's Revenue falls into.


TSE:197A
14GF Score
Tauns Laboratories Inc TSE:197A
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14,369 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of 円14,369 Mil mean?
Tauns Laboratories (TSE:197A) has a Revenue of 円14,369 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Revenue too high?
Tauns Laboratories' current Revenue is 円14,369 Mil. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Revenue compare to ISRG and BDX?
Tauns Laboratories' Revenue of 円14,369 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Revenue is 円14,369 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Revenue of 円14,369 Mil. The current Revenue is 円14,369 Mil. Tauns Laboratories' overall GF Score™ is 14/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Revenue is 円14,369 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score

Get the complete analysis for TSE:197A

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円509.00
Price